期刊文献+

血N端B型钠尿肽原对心力衰竭诊断价值及与心功能分级关系的探讨 被引量:14

Study on value of N-terminal proBNP to the diagnosis of heart failure and its relationship with cardiac functional grading
原文传递
导出
摘要 目的:评价血N-端B型钠尿肽原水平对心力衰竭的诊断价值及与心功能分级之间的相关性。方法:对122例心血管疾病患者根据NYHA心功能分级分为Ⅰ、Ⅱ、Ⅲ、Ⅳ组。同期本院体检中心健康体检者20例作为对照组。测定血N-端B型钠尿肽原浓度,心脏超声测量左室舒张末内径、左室短轴缩短率、左室射血分数等指标。其中20例患者于抗心力衰竭治疗10d后复测血N-端B型钠尿肽原浓度,进行统计学分析。结果:心力衰竭患者血N-端B型钠尿肽原浓度随NYHA分级增加而增高,且均高于对照组(P<0.01)。对照组、NYHAⅠ、Ⅱ组间的左室舒张末内径、左室短轴缩短率和左室射血分数差异无统计学意义(P>0.05)。NYHA分级与N-端B型钠尿肽原及左室舒张末内径呈正相关性,与左室短轴缩短率和左室射血分数呈负相关,其中与N-端B型钠尿肽原相关程度最高。结论:N-端B型钠尿肽原水平在心力衰竭患者中明显升高,是反映心力衰竭严重程度的指标。 Objective To evaluate the value of N-terminal proBNP to the diagnosis of heart failure and the its relationship with cardiac functional grading. Methods One hundred and twenty-two patients with cardiovascular disease were divided into NYHA Ⅰ、Ⅱ、Ⅲand Ⅳ groups. Another 20 normal people were as controls. Blood concentration of N terminal proBNP was measured. Echocardiographic measurements of LVDD, LVFS and LVEF were performed. Blood concentration of N-terminal proBNP was measured again in 20 patients after anti-heart failure therapy for 10 days. Results The blood concentration of N-terminal proBNP was increased with NYHA grade and was higher than that in control group (P〈0.01). There was no statistic difference of values of LVDD, LVFS and LVEF among NYHAⅠ, NYHA Ⅱ and control groups(P〉0.05). NYHA grading was positively correlated with N-terminal proBNP and LVDD, but negatively correlated with LVFS and LVEF. The correlation between NYHA and N-terminal proBNP was most significant. Conclusion The blood N-terminal proBNP increases significantly and it is an index to assess the severity of heart failure.
作者 金焱 刘东亮
出处 《中华实用诊断与治疗杂志》 2009年第9期850-851,854,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 心力衰竭 N端B型钠尿肽原 诊断价值 心功能分级 Heart failure N terminal proBNP diagnostic value cardiac functional grading
  • 相关文献

参考文献13

  • 1Schulz H, Lanqvik T A, Lund S E, et al. Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma[J]. Scand J Clin l.ab Invest, 2001, 61( 1 ) : 33-42.
  • 2Grantham J A, Borgeson D D, Burnett J C Jr, et al. BNP: Pathophysiological and potential theraperic roles in acute congestive heart failure[J]. Am J Physiol,1997,272(4 Pt 2):1077- 1083.
  • 3Fonseca C, SarmentoP M, Mincz A, et al. Comparative value of BNP and NT-proBNP in diagnosis of heart failure[J]. Rev Port Cardiol,2006,23(7-8) :979 991.
  • 4Emdin M, Passino C, Prontera C, et al. Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure [J ]. Clin Chem, 2007, 53 ( 7 ): 1289- 1297.
  • 5Stewart S, Malcntyre K, Hole D J, et al. More malignant than cancer? Five-year survival following a first admission for heart failure[J]. Eur J Heart Fail,2001,3(3):315-322.
  • 6Pfeffer M A, Braunwald E, Moy4 L A, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infraction: Results of the survival and ventricular enlargement trial[J]. N Engl J Med, 1992,327 (10):669- 677.
  • 7Amir O, Paz H, Ammar R, et al. Usefulness and predictive value of circulating NT proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center[J]. Isr Med Assoc J,2008,10(2): 152-153.
  • 8谢桥涛,宋建平,戴敏,谷云飞,杨俊华,蒋文平.Tei指数与心功能分级及血NT-proBNP的相关性研究[J].实用诊断与治疗杂志,2007,21(4):256-258. 被引量:10
  • 9付海霞,张嘉莹,李庚山,许家俐.慢性心力衰竭患者血浆脑钠肽水平研究[J].实用诊断与治疗杂志,2006,20(10):705-707. 被引量:25
  • 10Hunt S A, Abraham W T, Chin M H, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult[J]. Circulation,2005,112(12):e154- 235.

二级参考文献27

  • 1黄熙,臧益民.丹参酮ⅡA磺酸钠心血管药理[J].国外医学(中医中药分册),1995,17(1):9-12. 被引量:66
  • 2李越,李岩密,孟素云,温朝阳.Tei指数及相关基本参数评估不同左心室功能状态的研究[J].中国医学影像技术,2005,21(8):1205-1208. 被引量:35
  • 3付海霞,张嘉莹,李庚山,许家俐.慢性心力衰竭患者血浆脑钠肽水平研究[J].实用诊断与治疗杂志,2006,20(10):705-707. 被引量:25
  • 4Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease[J]. Adv Clin Chem,2005,40(1):1.
  • 5Dries D L, Stevenson L W. Brain natriuretic peptide as bridge to therapy for heart failure[J]. Lancet, 2000,355(9210):1112.
  • 6Tsutamoto T, Wada A, Sakai H, et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure[J]. J Am Coll Cardiol, 2006,47(3):582.
  • 7Maeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular enddiastolic pressure in patients with symptomatic left ventricular dysfunction[J]. Am Heart J, 1998,135(5Pt):825.
  • 8Morrison L K, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea[J]. J Am Coll Cardiol, 2002,39(2):202.
  • 9Maisel A S, Koon J, Krishnaswamy P, et al. Utility of Bnatriuretie peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J]. Am Heart J, 2001,141 (3): 367.
  • 10Task force for the diagnosis and treatment of chronic heart failure of European. Society of cardiology. Guidelines for the diagnosis and treatment of chronic heart failure[J]. Eur Heart J,2001,22(17):1527.

共引文献43

同被引文献94

引证文献14

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部